Given the high correlation of HSP60 with the presence of ELSs in the RA joints, we assessed the longitudinal effect of rituximab therapy on synovial HSPD1 expression before and after B cell depletion in the R4RA biopsy-driven randomized trial (Figure 6A) (27, 28). Here, HSPD1 is linked to rheumatoid arthritis.